We performed serum testing for IgG antibodies against Coxiella burnetii (phase I and phase II) and analyzed questionnaire data from 4,437 adults ≥ 20 years of age who participated in the National Health and Nutrition Examination Survey 2003-2004 survey cycle. National Q fever seroprevalence was determined by enzyme-linked immunosorbent assay and confirmed by using immunofluorescent antibody testing. Overall seroprevalence for Coxiella burnetii was 3.1% (95% confidence interval [CI] = 2.1-4.3%) among 4,437 adults ≥ 20 years of age. Coxiella burnetii age-adjusted antibody prevalence was higher for men than for women (3.8%, 95% CI = 2.7-5.2% versus 2.5%, 95% CI = 1.5-3.7%, respectively, P < 0.05). Mexican Americans had a significantly higher antibody prevalence (7.4%, 95% CI = 6.6-8.3%) than either non-Hispanic whites (2.8%, 95% CI = 1.7-4.3%) or non-Hispanic blacks (1.3%, 95% CI = 0.6-2.5%) ( P < 0.001). Multivariate analysis showed that the risk for Q fever antibody positivity increased with age and was higher among persons who were foreign-born, male, and living in poverty. These findings indicate that the national seroprevalence of Q fever in the United States is higher than expected on the basis of case numbers reported to the Centers for Disease Control and Prevention from state health departments. Potential differences in risk for exposure by race/ethnicity warrant further study.
INTRODUCTION
Q fever is a zoonotic disease with acute and chronic stages caused by the organism Coxiella burnetii . The disease was first discovered in Australia in the 1930s and now has worldwide distribution. 1 Many vertebrate species can be infected, although cattle, sheep, and goats are considered the primary reservoirs. Transmission to humans usually occurs by contact with animal birth products or by inhalation of pathogencontaminated dust or aerosols from infected animals. Humans are highly susceptible to the disease with an infectious dose estimate of one to ten organisms. [2] [3] [4] There are two distinct antigenic phases in which humans develop antibody responses. In acute infection, an antibody response primarily to C. burnetii phase II antigen is evident. In chronic infection, an antibody response to C. burnetii phase I antigen is evident. 5 Clinical symptoms develop in approximately half of infected persons, and the most common clinical manifestation of acute disease is a flu-like illness, with pneumonia and hepatitis occurring in more severe cases. The mortality rate for acute Q fever is low (1-2%). 6 Chronic Q fever most typically results in culture-negative endocarditis in persons with pre-existing valvulopathies. Although chronic Q fever is rare (< 5% of acutely infected patients), the fatality rate for chronic Q fever endocarditis cases is much higher and may exceed 65%. 7 Coxiella burnetii is categorized as a category B bioterrorism agent by the Centers for Disease Control and Prevention (CDC) and it has been previously weaponized for use in biological warfare. 8 Q fever became a nationally notifiable disease in 1999; approximately 80 cases are reported each year to the CDC with a peak of 171 cases in 2007 and an average annual reported incidence of 0.28 cases per million persons. 2 However, because many human infections are asymptomatic or have nonspecific symptoms and laboratory testing capacity is limited, the disease is underdiagnosed and underreported, which makes it difficult to reliably assess true incidence and geographic distribution. A nationwide seroprevalence study for this disease has never been performed and is an important step to more accurately assess the incidence and impact of this disease in the United States.
The National Health and Nutrition Examination Survey (NHANES) program is a series of large nationally representative surveys conducted by the National Center for Health Statistics. These surveys furnish the opportunity to estimate Q fever seroprevalence nationwide and provide a benchmark for further research. To determine a population-based seroprevalence of Q fever, we performed serologic analyses on serum samples for IgG antibody to Coxiella burnetii (phase I and phase II) collected from adults ≥ 20 years of age participating in the NHANES 2003-2004 survey cycle.
MATERIALS AND METHODS
Survey design and collection of data. The NHANES sample was selected on the basis of a stratified, multistage, probability cluster design. NHANES has been conducted continuously since 1999 and periodically before then. Data are collected through household interviews, standardized physical examinations, and collection of biological samples at mobile examination centers. A nationally representative sample is selected annually, but data are released in twoyear cycles to protect confidentiality and increase statistical reliability. NHANES is reviewed and approved annually by an institutional review board. Informed written consent was obtained from all participants or their parents or guardians. Descriptions of the survey design and sampling methods have been published elsewhere. 9 The CDC Institutional Review Board reviewed and approved the study protocol.
To ensure adequate sample size, NHANES 1999-2006 oversampled low-income persons, adolescents 12-19 years of age, persons ≥ 60 years of age, non-Hispanic blacks, and Mexican Americans. Q fever seropositive results were weighted to represent the total civilian non-institutionalized U.S. household population to account for oversampling and nonresponse to the household interview and physical examination. The weights were further ratio-adjusted by age, sex, and race/ ethnicity to the U.S. population control estimates from the Current Population Survey adjusted for undercounts. 10, 11 Testing for IgG antibodies against Coxiella burnetii was completed for all eligible participants ≥ 20 years of age for the 2003-2004 survey cycle. Race/ethnicity was defined by self report and classified as non-Hispanic white, non-Hispanic black, or Mexican American. Persons not classified into one of these groups were categorized as other race and were only included in analyses when all racial/ethnic groups were combined. Poverty index was calculated by dividing the total family income by the U.S. poverty threshold, adjusted for family size and coded as below poverty (poverty index < 1) or at or above poverty (poverty index ≥ 1). Other cofactors examined for their association with seropositivity to Q fever included sex, age (20-29, 30-39, 40-49, 50-59, 60-69, and ≥ 70 years), birth outside the U.S., education (high school graduate, less than high school education), military status, and history of ever being diagnosed with a liver condition.
Statistical analysis. All statistical procedures were conducted using SUDAAN, a family of statistical procedures for analysis of data from complex sample surveys. 12 Estimates of seroprevalence were weighted to represent the U.S. population; 95% confidence intervals (CIs) were calculated using an exact binomial method. 13 Standard errors were calculated using the Taylor series linearization method to account for the complex sample design. 12 Estimates with relative standard errors greater than 30% or less than 12 degrees of freedom did not meet standards of reliability or precision and those estimates are not presented. Estimated total numbers of infected persons and corresponding confidence limits were calculated by multiplying weighted prevalence estimates by the noninstitutionalized U.S. population at the midpoint of the survey cycle (2003) (2004) as determined by the U.S. Census Bureau Current Population Survey. 14 A t-statistic from a linear contrast procedure was used to compare prevalence estimates between levels of a given cofactor with P values < 0.05 considered significant. When we compared prevalence across population subgroups, estimates were age standardized by the direct method to the age distribution of the 2000 U.S. population for the seven age groups used in the analyses. No adjustments for multiple comparisons were made.
A backward stepwise logistic modeling procedure in SUDAAN was used to determine cofactors that were independently associated with Q fever antibody positivity. Cofactors with a Satterthwaite-adjusted F statistic with P < 0.05 were considered significant.
Laboratory methods. An enzyme-linked immunosorbent assay (ELISA) was used to initially screen serum specimens for IgG antibodies against phase II C. burnetii (PanBio Inc., Columbia, MD) according to the manufacturer's instructions. Any serum sample test result either positive or equivocal by ELISA was then tested by an indirect immunofluorescent antibody (IFA) assay to confirm the ELISA data and to obtain end point titers for IgG against phase I and phase II C. burnetii antigens. Q fever seropositivity was defined as a phase I or phase II IgG titer ≥ 1:16 by IFA. The IFA test was performed by the method of Philip and others 15 and adapted to C. burnetii (purified phases I and II, strain Nine Mile; Rocky Mountain Laboratories, Hamilton, MT) as described elsewhere. 16 Phase I antibody levels much greater than phase II antibody levels and phase I titers greater than 1:800 were considered indicative of potential chronicity. Definitive diagnosis of chronic Q fever requires additional clinical assessments that were not part of this study.
RESULTS
In NHANES 2003-2004, 6,916 persons ≥ 20 years of age were selected and 5,041 (72.9% of those selected) were interviewed. Of these persons, 4,742 (94.1%) were examined and 4,437 (93.6%) of those examined had consented to phlebotomy and had sufficient serum collected to test for IgG antibodies against C. burnetti . Percentage of sera tested among those examined was slightly lower among non-Hispanic blacks (91.5%) than among non-Hispanic whites (94.1%) and Mexican Americans (94.1%) ( P < 0.05). Fewer females (92.7%) than males (94.5%) ( P < 0.01) and fewer persons with less education (less than high school completed) (92.4%) than persons with more education (more than high school completed) (94.5%) ( P < 0.05), had their sera tested. The percent of persons with sera tested among those examined did not vary by age, poverty status, birth outside the U.S., military status, or liver condition.
Of the 4,437 persons tested for C. burnetii IgG antibodies in our sample, 180 specimens were antibody positive, confirmed by an IFA titer ≥ 1:16. This corresponds to a weighted U.S. prevalence for persons ≥ 20 years of age of 3.1% (95% CI = 2.1-4.3%). The nationwide population estimate for Q fever antibody prevalence in this age group is 6.1 million persons (95% CI = 4.2-8.5 million). The geometric mean titer for phase II IgG antibody was 95 (range = 16-4,096). The serologic results of one person were indicative of potential chronicity (IFA IgG antibody phase I = 1:2048 and phase II = 1:512).
Seroprevalence for the total population increased with age and was highest among persons ≥ 70 years of age (4.3%) ( Figure 1 ) . A linear t -test for trend for the relationship between age and Q fever seropositivity was statistically significant ( P < 0.01). Coxiella burnetii age-adjusted antibody prevalence was higher for men than for women (3.8%, 95% CI = 2.7-5.2% versus 2.4%, 95% CI = 1.5-3.8%), respectively ( P < 0.05). Mexican Americans had a significantly higher ageadjusted antibody prevalence (7.4%, 95% CI = 6.6-8.3%) than either non-Hispanic whites (2.8%, 95 CI = 1.7-4.3%) or non-Hispanic blacks (1.4%, 95% CI = 0.6-2.5%) ( P < 0.001) ( Table 1 ) . Foreign-born participants were significantly more likely to be seropositive for Q fever (7.4%, 95% CI = 4.9-10.6%) than U.S.-born participants (2.3%, 95% CI = 1.5-3.4%) ( P < 0.01) ( Table 1 ) . Among Mexican Americans, there was no significant age-adjusted difference between foreign-born and U.S.-born participants, with 8.2% (95% CI = 6.6-10.1%) of foreign-born Mexican-Americans being seropositive for Q fever compared with 6.5% (95% CI = 4.4-9.2%) ( P > 0.05) of U.S. born Mexican Americans (estimate of standard errors may be unstable because of degrees of freedom < 10). However, white foreign-born participants had a much higher age-adjusted seroprevalence (11.1%, 95% CI = 5.5-19.2%) than white U.S. born participants (2.3%, 95% CI = 1.4-3.6%) ( P < 0.01).
Using multivariate analysis, we showed that foreign birth was the strongest predictor of Q fever seropositivity, followed by age ( Table 2 ) . Foreign-born persons were more than four times more likely to be seropositive than U.S. born persons, and persons ≥ 60 years of age were more than three times more likely to be seropositive than persons 20-39 years of age. Male sex and living in poverty also remained as positive predictors in the model. Other risk factors examined including military service, years of education, and liver disease were not associated with Q fever seropositivity in the multivariate model. The number of persons seropositive for Q fever was too small to evaluate interactions within the data.
DISCUSSION
The overall nationwide Q fever seroprevalence of 3.1% is much higher than expected based on the number of cases reported yearly to CDC. Factors that were significant predic-tors of Q fever seropositivity such as living in poverty, male sex, and foreign birth may be related to occupational exposures. Q fever has historically been linked to workers with occupations that have direct animal contact (e.g., farm or slaughterhouse work). 6 For example, a recent study among U.S. veterinarians found a Q fever seroprevalence of 22.2% and an association to veterinarians working with cattle and wildlife. 17 Stable estimates by occupational exposure could not be produced in this study because data on agricultural occupations were limited.
These data also indicate that there are potential differences in risk for exposure by race/ethnicity, although these differences were no longer significant after controlling for age, sex, and foreign birth. Differences in race/ethnicity may be related to varying exposures by geographic area or occupations indicative of a rural lifestyle but also may be attributable to other unknown factors. Potential differences in risk for exposure by race/ethnicity and foreign birth warrant further study to investigate reasons for these differences that may be responsive to preventive measures. The findings in this study are subject to limitations. Because only two years of NHANES data were used for this study, the small number of Q fever seropositive persons identified does not enable identification of risk in certain subpopulations. In addition, NHANES is a nationally representative survey, and is therefore not designed to give estimates in smaller geographic areas.
Previous research supports our findings that risk increases with age and is more likely among males. 18, 19 There have also been recent reports of Q fever cases among U.S. military personnel deployed to Iraq and Afghanistan, which indicate an emerging at-risk group for occupational exposure. [20] [21] [22] This survey did not find military service to be a significant risk factor for seropositivity. However, NHANES is designed to be representative of the U.S. population as a whole and it is difficult to ensure adequate sample representation for a small occupational group. A serosurvey specific for recent military service members would be necessary to accurately assess this potential risk factor.
This study provides the first national estimate of Q fever seroprevalence among adults ≥ 20 years of age in the United States. These data can be used to aid state and local health departments by providing estimates of baseline levels of disease to assist in determining appropriate investigational resources for naturally occurring outbreaks. Because Q fever is a category B bioterrorism agent, it also complements current bioterrorism preparedness initiatives by helping to establish the magnitude of disease burden in the United States, which is vital to detection of and response to any bioterrorism event.
